Intralytix and BioPhage partner to develop bacteriophage treatments of human wounds infected with S. aureus

Intralytix, Inc. announced that the Company is partnering with BioPhage Therapeutics Limited to deve...

Ascendis Pharma A/S Showcases New Data on Rare Disease Product Pipeline at ENDO 2017

Ascendis Pharma A/S ,biopharmaceutical company that utilizes its innovative TransCon technology to a...

Teva announces FDA approval of Austedo tablets for chorea associated with huntington’s disease

Teva Pharmaceutical Industries Ltd. announced that the U.S. FDA has approved AUSTEDO™ (deutetrabenaz...

Aurinia Announces Development Plans for Voclosporin in Europe and Japan

Aurinia Pharmaceuticals Inc announced the outcome of discussions with both the EMA and the PMDA in J...

Medidata Wins Informa CARE Award for “Clinical Trial Partnership of the Year”

Medidata the leading global provider of cloud-based technology and data analytics for clinical resea...

  • Intralytix and BioPhage partner to develop bacteriophage treatments of human wounds infected with S. aureus

  • Ascendis Pharma A/S Showcases New Data on Rare Disease Product Pipeline at ENDO 2017

  • Teva announces FDA approval of Austedo tablets for chorea associated with huntington’s disease

  • Aurinia Announces Development Plans for Voclosporin in Europe and Japan

  • Medidata Wins Informa CARE Award for “Clinical Trial Partnership of the Year”

Projects

NuMedii, Inc. Announces New Partnership To Discover New Treatments For Idiopathic Pulmonary Fibrosis

NuMedii, Inc announced the formation of a strategic partnership with Three Lakes Partners, LLC, to discover and advance new treatments for idiopathic pulmonary fibrosis (IPF) based on NuMedii’s

Read more »
Amri Announces Strategic Alliance To Advance Mass Spectrometry Capabilities For Drug Discovery

AMRI , a global contract research and manufacturing organization working to improve patient outcomes and quality of life, has entered an alliance with Bruker Daltonics and HighRes Biosolutions to deve

Read more »
Takeda Presents $1 Million Gift to the Koch Institute for Integrative Cancer Research

Takeda Pharma and the Koch Institute for Integrative Cancer Research at MIT jointly announced that Takeda will support groundbreaking science in immuno-oncology at the Koch Institute. Over the next tw

Read more »

News

LEO Pharma appoints Chris Posner to lead US business

LEO Pharma announced that it appointed Chris Posner Executive Vice President Region US and President & CEO, LEO Pharma, Inc. President Region US and President & CEO, LEO Pharma, Inc.  

Read more »
Teva Announces Launch of Generic Glumetza in the United Stat

Teva Pharmaceutical Industries Ltd announced the launch of generic Glumetza®1 (metformin hydrochloride extended-release tablets), 500 mg and 1000 mg, in the U.S. Metformin hydrochloride extended-rel

Read more »
ANI Pharmaceuticals Announces Launch of Pindolol Tablets

ANI Pharmaceuticals, Inc. announced the launch of Pindolol Tablets, 5mg and 10mg, which is used in the treatment of hypertension. The annual U.S. market for Pindolol Tablets is approximately $10 milli

Read more »

Market Reports

KBI Biopharma Acquires Alliance Protein Laboratories, Expands Biophysical Capabilities

KBI Biopharma, Inc. (KBI) has agreed to acquire the assets of San Diego-based Alliance Protein Laboratories (Alliance), a leading analytical services company specializing in biophysical characterizati

Read more »
Xynomic Pharma Has Acquired Worldwide Rights of Abexinostat

Xynomic Pharmaceuticals, Inc., an oncology drug research and development company, today announced that it has acquired exclusive worldwide rights to develop, manufacture and commercialize Abexinostat,

Read more »
Quotient Clinical Acquires Contract Drug Developer, Manufacturer QS Pharma

Quotient Clinical , the early phase drug development services provider announces that it has acquired QS Pharma, the contract development and manufacturing organisation (CDMO), based near Philadelphia

Read more »

Press Releases

FierceBiotech’sDrug Development Forum Attracts Executive-Level Biopharma Professionals for Second Annual Conference in Boston This September

Attendees of FierceBiotech’s 2ndAnnual Drug Development Forum will obtain essential funding strategies and more productive R&D through executive-level networking opportunities. Convening at the

Read more »
FDA chooses Zepsyre from PharmaMar to explore potential development for pediatric cancers

The Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) of the FDA, has invited PharmaMar to participate in this ODAC, giving a presentation to provide backgroun

Read more »
Evoke Pharma Enters Agreement with Rho to Submit NDA for Gimoti

Evoke Pharma Inc , a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases announced that it has entered into an agreement with Rho, Inc., a regulatory consulting a

Read more »

Featured Events

Subscribe To Our Newsletter

Security Q:How many eyes has a typical person? (ex: 1)
Name:
Email: